292 related articles for article (PubMed ID: 29474296)
1. Assessment of Glaucomatous Damage After Boston Keratoprosthesis Implantation Based on Digital Planimetric Quantification of Visual Fields and Optic Nerve Head Imaging.
Ali MH; Dikopf MS; Finder AG; Aref AA; Vajaranant T; de la Cruz J; Cortina MS
Cornea; 2018 May; 37(5):602-608. PubMed ID: 29474296
[TBL] [Abstract][Full Text] [Related]
2. Glaucoma Risk Factors and Outcomes Following Boston Keratoprosthesis Type 1 Surgery.
Geoffrion D; Harissi-Dagher M
Am J Ophthalmol; 2021 Jun; 226():56-67. PubMed ID: 33493469
[TBL] [Abstract][Full Text] [Related]
3. Glaucoma associated with Boston type I keratoprosthesis.
Kamyar R; Weizer JS; de Paula FH; Stein JD; Moroi SE; John D; Musch DC; Mian SI
Cornea; 2012 Feb; 31(2):134-9. PubMed ID: 22134402
[TBL] [Abstract][Full Text] [Related]
4. Prevalence, progression, and impact of glaucoma on vision after Boston type 1 keratoprosthesis surgery.
Talajic JC; Agoumi Y; Gagné S; Moussally K; Harissi-Dagher M
Am J Ophthalmol; 2012 Feb; 153(2):267-274.e1. PubMed ID: 21982110
[TBL] [Abstract][Full Text] [Related]
5. Glaucoma Management in Patients With Aniridia and Boston Type 1 Keratoprosthesis.
Nascimento E Silva R; Shen LQ; Chiou CA; Shanbhag SS; Paschalis EI; Pasquale LR; Colby KA; Dohlman CH; Chodosh J; Alves MR
Am J Ophthalmol; 2019 Nov; 207():258-267. PubMed ID: 31247168
[TBL] [Abstract][Full Text] [Related]
6. Glaucoma progression and role of glaucoma surgery in patients with Boston keratoprosthesis.
Crnej A; Paschalis EI; Salvador-Culla B; Tauber A; Drnovsek-Olup B; Shen LQ; Dohlman CH
Cornea; 2014 Apr; 33(4):349-54. PubMed ID: 24531120
[TBL] [Abstract][Full Text] [Related]
7. Blood Levels of Tumor Necrosis Factor Alpha and Its Type 2 Receptor Are Elevated in Patients with Boston Type I Keratoprosthesis.
Paschalis EI; Taniguchi EV; Chodosh J; Pasquale LR; Colby K; Dohlman CH; Shen LQ
Curr Eye Res; 2019 Jun; 44(6):599-606. PubMed ID: 30632412
[No Abstract] [Full Text] [Related]
8. Glaucoma Evaluation and Management in Eyes With Boston Type 1 and Aurolab Keratoprostheses in an Indian Cohort.
Senthil S; Mohamed A; Shanbhag SS; Durgam SS; Bagga B; Sangwan VS; Basu S
Cornea; 2022 May; 41(5):552-561. PubMed ID: 35383615
[TBL] [Abstract][Full Text] [Related]
9. Cyclophotocoagulation in the Control of Glaucoma in Patients With the Boston Keratoprosthesis Type 1.
Jabbour S; Harissi-Dagher M; Agoumi Y; Singh H; Robert MC
Cornea; 2020 Feb; 39(2):181-185. PubMed ID: 31335536
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the Role and Timing of Glaucoma Surgery in Boston Keratoprosthesis Type 1 Patients.
Geoffrion D; Hassanaly SI; Marchand M; Daoud R; Agoumi Y; Harissi-Dagher M
Am J Ophthalmol; 2022 Mar; 235():249-257. PubMed ID: 34543660
[TBL] [Abstract][Full Text] [Related]
11. Reliability of Several Glaucoma Tests in Patients With Boston Type 1 Keratoprosthesis.
Akpek EK; Karakus S; Yohannan J; Jabbour S; Sotimehin AE; Li G; Ramulu PY
Cornea; 2022 Mar; 41(3):310-316. PubMed ID: 34133397
[TBL] [Abstract][Full Text] [Related]
12. Predictors of visual outcomes following Boston type 1 keratoprosthesis implantation.
Ahmad S; Akpek EK; Gehlbach PL; Dunlap K; Ramulu PY
Am J Ophthalmol; 2015 Apr; 159(4):739-47. PubMed ID: 25555801
[TBL] [Abstract][Full Text] [Related]
13. Safety of Concurrent Boston Type I Keratoprosthesis and Glaucoma Drainage Device Implantation.
Lenis TL; Chiu SY; Law SK; Yu F; Aldave AJ
Ophthalmology; 2017 Jan; 124(1):12-19. PubMed ID: 27614591
[TBL] [Abstract][Full Text] [Related]
14. Sequential versus concomitant surgery of glaucoma drainage implant and Boston keratoprosthesis type 1.
Patel V; Moster MR; Kishfy L; Barkan J; Zhan T; Raber IM; Ayres BD; Pro MJ; Waisbourd M
Eur J Ophthalmol; 2016 Nov; 26(6):556-563. PubMed ID: 27079206
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of pars plana glaucoma drainage implant in Boston type 1 keratoprosthesis surgery.
Huh ES; Aref AA; Vajaranant TS; de la Cruz J; Chau FY; Cortina MS
J Glaucoma; 2014 Jan; 23(1):e39-44. PubMed ID: 24370810
[TBL] [Abstract][Full Text] [Related]
16. Probing mechanisms and improving management of glaucoma following Boston keratoprosthesis surgery.
Geoffrion D; Koenekoop RK; Harissi-Dagher M
Acta Ophthalmol; 2023 Mar; 101(2):242-243. PubMed ID: 36794627
[TBL] [Abstract][Full Text] [Related]
17. Glaucoma associated with keratoprosthesis.
Netland PA; Terada H; Dohlman CH
Ophthalmology; 1998 Apr; 105(4):751-7. PubMed ID: 9544652
[TBL] [Abstract][Full Text] [Related]
18. Complications associated with Boston keratoprosthesis type 1 and glaucoma drainage devices.
Robert MC; Pomerleau V; Harissi-Dagher M
Br J Ophthalmol; 2013 May; 97(5):573-7. PubMed ID: 23435225
[TBL] [Abstract][Full Text] [Related]
19. Reversible structural and functional changes after intraocular pressure reduction in patients with glaucoma.
Waisbourd M; Ahmed OM; Molineaux J; Gonzalez A; Spaeth GL; Katz LJ
Graefes Arch Clin Exp Ophthalmol; 2016 Jun; 254(6):1159-66. PubMed ID: 26995555
[TBL] [Abstract][Full Text] [Related]
20. Technique of combined glaucoma tube shunt and keratoprosthesis implantation.
Law SK; Huang JS; Nassiri N; Moghimi S; Nilforushan N; Parham A; Moossai J; Kim M; Caprioli J; Aldave AJ
J Glaucoma; 2014; 23(8):501-7. PubMed ID: 25275831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
